Division of Infectious Diseases, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Kaiser Permanente Washington Health Research Institute, Seattle.
JAMA Netw Open. 2022 Dec 1;5(12):e2247540. doi: 10.1001/jamanetworkopen.2022.47540.
IMPORTANCE: HIV self-testing (HIVST) is a promising strategy to expand the HIV care continuum, particularly among priority populations at high risk of HIV infection. However, little is known about HIVST uptake among men who have sex with men (MSM) outside of clinical trial settings. OBJECTIVE: To evaluate HIVST use among urban MSM in the US who reported testing within the past 12 months. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study of adult MSM in the 2017 National HIV Behavioral Surveillance system, which used venue-based sampling methods to collect data related to HIV testing, receipt of prevention services, and risk factors for HIV, was conducted at 588 venues in 23 urban areas in the contiguous US and Puerto Rico. All participants were offered HIV testing. Adult cisgender MSM who reported HIV-negative or unknown HIV status and obtained HIV testing in the past 12 months were included. Data for this study were collected between June 4, 2017, and December 22, 2017, and analyzed between October 23, 2020, and August 20, 2021. MAIN OUTCOMES AND MEASURES: Self-reported HIVST in the past year. Adjusted prevalence ratios (aPRs) using survey weights were calculated to assess factors associated with HIVST. RESULTS: A total of 6563 MSM in 23 urban areas met inclusion criteria, of whom 506 (7.7%) individuals reported HIVST in the past year. The median age of self-testers was 29 (IQR, 25-35) years, 52.8% had completed college, and 37.9% reported non-Hispanic White race. One self-tester reported seroconverting in the prior 12 months, and an additional 10 self-testers were diagnosed with HIV during the survey. HIVST was associated with sexual orientation disclosure (aPR, 10.27; 95% CI, 3.45-30.60; P < .001), perceived discrimination against people with HIV (aPR, 1.53; 95% CI, 1.09-2.03; P = .01), younger age (aPR, 0.74; 95% CI, 0.66-0.84; P < .001), higher educational level (aPR, 1.20; 95% CI, 1.04-1.37; P = .01), and higher income levels (aPR, 1.18; 95% CI, 1.04-1.32; P = .009). No association was noted with condomless anal sex (aPR, 0.96; 95% CI, 0.88-1.06, P = .88), sexually transmitted infections (aPR, 0.96; 95% CI, 0.70-1.30; P = .77), or preexposure prophylaxis use (aPR, 0.99; 95% CI, 0.75-1.30; P = .92). CONCLUSIONS AND RELEVANCE: In this study, HIVST was relatively uncommon in this sample of urban MSM. HIVST may not be reaching those with lower socioeconomic status or who have not disclosed their sexual identity. The findings of this study suggest that efforts to increase HIVST should focus on engaging underserved and vulnerable subgroups of MSM.
重要性:HIV 自我检测(HIVST)是扩大 HIV 护理连续体的一项有前途的策略,特别是在高 HIV 感染风险的优先人群中。然而,人们对非临床试验环境中男男性行为者(MSM)的 HIVST 使用率知之甚少。
目的:评估过去 12 个月内在美国城市 MSM 中 HIVST 的使用情况。
设计、地点和参与者:2017 年全国 HIV 行为监测系统的一项横断面研究,该系统使用基于场所的抽样方法收集与 HIV 检测、预防服务的获得以及 HIV 风险因素相关的数据,在 美国和波多黎各的 23 个城市的 588 个场所进行。所有参与者都提供了 HIV 检测。纳入了报告 HIV 阴性或未知 HIV 状态且在过去 12 个月内获得 HIV 检测的成年顺性别 MSM。本研究的数据收集于 2017 年 6 月 4 日至 2017 年 12 月 22 日之间,分析于 2020 年 10 月 23 日至 2021 年 8 月 20 日之间进行。
主要结果和措施:过去一年中自我报告的 HIVST。使用调查权重计算调整后的患病率比(aPR),以评估与 HIVST 相关的因素。
结果:在 23 个城市中,共有 6563 名 MSM 符合纳入标准,其中 506 名(7.7%)个体报告在过去一年中进行了 HIVST。自我检测者的中位年龄为 29 岁(IQR,25-35 岁),52.8%完成了大学学业,37.9%报告为非西班牙裔白人。一名自我检测者报告在过去 12 个月中出现血清转换,另外 10 名自我检测者在调查期间被诊断出 HIV。HIVST 与性取向披露(aPR,10.27;95%CI,3.45-30.60;P<0.001)、针对 HIV 患者的歧视感知(aPR,1.53;95%CI,1.09-2.03;P=0.01)、年龄较小(aPR,0.74;95%CI,0.66-0.84;P<0.001)、较高的教育水平(aPR,1.20;95%CI,1.04-1.37;P=0.01)和较高的收入水平(aPR,1.18;95%CI,1.04-1.32;P=0.009)相关。与无保护的肛交性行为(aPR,0.96;95%CI,0.88-1.06,P=0.88)、性传播感染(aPR,0.96;95%CI,0.70-1.30;P=0.77)或暴露前预防用药(aPR,0.99;95%CI,0.75-1.30;P=0.92)无关。
结论和相关性:在这项研究中,HIVST 在该城市 MSM 样本中相对较少见。HIVST 可能无法覆盖那些社会经济地位较低或尚未披露其性身份的人。这项研究的结果表明,增加 HIVST 的努力应侧重于接触服务不足和易受感染的 MSM 亚群。
JAMA Netw Open. 2022-12-1
PLOS Glob Public Health. 2025-5-12
JMIR Public Health Surveill. 2025-2-28
JMIR Public Health Surveill. 2025-1-16
Prev Med Rep. 2023-5-13
JAMA Intern Med. 2020-4-1